IN BRIEF: GBP40 Million MaxCyte Subscription Ahead Of Dual Listing
IN BRIEF: GBP40 Million MaxCyte Subscription Ahead Of Dual Listing
Read moreFri, 21st Feb 2020 11:53
IN BRIEF: GBP40 Million MaxCyte Subscription Ahead Of Dual Listing
Read moreLONDON TRADING UPDATES: Alliance Pharma 2020 Revenue Slips By 5%
Read moreUK TRADING UPDATE SUMMARY: Science Group To Beat Forecasts For 2020
Read moreMaxcyte Core Life Sciences Business Results To Beat Expectations
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreUK EXECUTIVE CHANGE SUMMARY: Danakali Hires Potash Mining Vet As COO
Read moreIN BRIEF: MaxCyte Interim Revenue Jumps And Loss Narrows
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreMaxCyte Hires Murphy As Finance Chief; Holtz Becomes Accounting Boss
Read more(Sharecast News) - Life sciences company MaxCyte named Amanda Murphy as its chief financial officer on Wednesday, succeeding long-time CFO Ron Holtz.
Read moreIN BRIEF: MaxCyte Says CARMA's Phase 1 MCY-M11 Trial Expanded
Read moreMaxCyte Sees Higher Interim Revenue, Confident On Long-Term Prospects
Read moreIN BRIEF: MaxCyte Signs APN401 Licensing Deal With Apeiron Biologics
Read moreUK TRADING UPDATE SUMMARY: Filta Launches Covid-19 Sanitising Service
Read moreMaxCyte Raises GBP25 Million To Fund Investments Ahead Of US IPO
Read more